Literature DB >> 31704479

A systematic review on the functional role of Th1/Th2 cytokines in type 2 diabetes and related metabolic complications.

Thabsile Mahlangu1, Phiwayinkosi V Dludla2, Tawanda M Nyambuya3, Vuyolwethu Mxinwa1, Sithandiwe E Mazibuko-Mbeje4, Ilenia Cirilli5, Fabio Marcheggiani6, Luca Tiano7, Johan Louw8, Bongani B Nkambule9.   

Abstract

The T-helper (Th1/Th2) paradigm is widely studied for its role in modulating an adaptive immune response, especially in relation to the onset of various autoimmune diseases. In fact, emerging evidence clearly shows an inverse relationship between Th1/Th2 cytokines and the development of type 2 diabetes (T2D) complications, which is accelerated by an exacerbated inflammatory state. Here, relevant studies reporting on any association between the levels of Th1/Th2 cytokines and the development of T2D were retrieved through major electronic databases such as The Cochrane Library, Embase and PubMed. Extracted evidence which mostly involved animal models and human subjects with T2D or metabolic syndrome was assessed for quality and risk of bias using the Downs and Black checklist and Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. Results strongly correlated raised Th1/Th2 cytokines such as interferon-gamma (IFN-γ)/interleukin (IL)-5 and IL-2/IL-5 ratios to T2D, and this was positively linked with the other complications including retinopathy and cardiovascular complications. Further, logistic regression analysis demonstrated that the Th1/Th2 ratios were significantly associated with impaired glucose homeostasis, abnormally enhanced lipid profiles, and insulin resistance. Although more studies making use of a larger sample size are required, current data suggest that optimal modulation of Th1/Th2 cytokines may be an important aspect in the management of T2D and its associated complications.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Inflammation; Insulin resistance; Metabolic syndrome; Th1/Th2 cytokines; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2019        PMID: 31704479     DOI: 10.1016/j.cyto.2019.154892

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  22 in total

1.  Effects of Dezocine and Sufentanil on Th1/Th2 Balance in Breast Cancer Patients Undergoing Surgery.

Authors:  Xudong Hu; Bing Luo; Qing Wu; Qingbiao Chen; Penghui Lu; Jie Huang; Xiaoxia Liang; Cheng Ling; Yiqun Li
Journal:  Drug Des Devel Ther       Date:  2021-12-02       Impact factor: 4.162

2.  The Transcriptome and Epigenome Reveal Novel Changes in Transcription Regulation During Pancreatic Rat Islet Maturation.

Authors:  Yu-Chin Lien; Xueqing Maggie Lu; Kyoung-Jae Won; Paul Zhiping Wang; Wendy Osei-Bonsu; Rebecca A Simmons
Journal:  Endocrinology       Date:  2021-11-01       Impact factor: 5.051

Review 3.  The impact of coenzyme Q10 on metabolic and cardiovascular disease profiles in diabetic patients: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Phiwayinkosi V Dludla; Tawanda M Nyambuya; Patrick Orlando; Sonia Silvestri; Vuyolwethu Mxinwa; Kabelo Mokgalaboni; Bongani B Nkambule; Johan Louw; Christo J F Muller; Luca Tiano
Journal:  Endocrinol Diabetes Metab       Date:  2020-03-14

Review 4.  Exploring the Comparative Efficacy of Metformin and Resveratrol in the Management of Diabetes-associated Complications: A Systematic Review of Preclinical Studies.

Authors:  Phiwayinkosi V Dludla; Sonia Silvestri; Patrick Orlando; Kwazi B Gabuza; Sithandiwe E Mazibuko-Mbeje; Tawanda M Nyambuya; Vuyolwethu Mxinwa; Kabelo Mokgalaboni; Rabia Johnson; Christo J F Muller; Luca Tiano; Johan Louw; Bongani B Nkambule
Journal:  Nutrients       Date:  2020-03-11       Impact factor: 5.717

5.  Blocking the LncRNA MALAT1/miR-224-5p/NLRP3 Axis Inhibits the Hippocampal Inflammatory Response in T2DM With OSA.

Authors:  Ping Du; Jiahui Wang; Yelei Han; Jing Feng
Journal:  Front Cell Neurosci       Date:  2020-05-12       Impact factor: 5.505

6.  Metformin and heart failure-related outcomes in patients with or without diabetes: a systematic review of randomized controlled trials.

Authors:  Phiwayinkosi V Dludla; Tawanda M Nyambuya; Rabia Johnson; Sonia Silvestri; Patrick Orlando; Sithandiwe E Mazibuko-Mbeje; Kwazi B Gabuza; Vuyolwethu Mxinwa; Kabelo Mokgalaboni; Luca Tiano; Christo J F Muller; Johan Louw; Bongani B Nkambule
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

7.  Association between Dietary Inflammatory Index and Type 2 diabetes mellitus in Xinjiang Uyghur autonomous region, China.

Authors:  WenHui Fu; Hualian Pei; Nitin Shivappa; James R Hebert; Tao Luo; Tian Tian; Dilibaier Alimu; Zewen Zhang; Jianghong Dai
Journal:  PeerJ       Date:  2021-07-16       Impact factor: 2.984

Review 8.  Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes.

Authors:  Alina Kuryłowicz; Krzysztof Koźniewski
Journal:  Molecules       Date:  2020-05-09       Impact factor: 4.411

Review 9.  Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Phiwayinkosi V Dludla; Patrick Orlando; Sonia Silvestri; Fabio Marcheggiani; Ilenia Cirilli; Tawanda M Nyambuya; Vuyolwethu Mxinwa; Kabelo Mokgalaboni; Bongani B Nkambule; Rabia Johnson; Sithandiwe E Mazibuko-Mbeje; Christo J F Muller; Johan Louw; Luca Tiano
Journal:  Int J Mol Sci       Date:  2020-05-04       Impact factor: 5.923

10.  Association between STAT4 gene polymorphism and type 2 diabetes risk in Chinese Han population.

Authors:  Jiaqi Cui; Rui Tong; Jing Xu; Yanni Tian; Juan Pan; Ning Wang; Huan Chen; Yanqi Peng; Sijia Fei; Wang Ling; Chaoying Guo; Juanchuan Yao; Wei Cui
Journal:  BMC Med Genomics       Date:  2021-06-27       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.